,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1092405,11089,Comparative Toxicogenomics Database (CTD),Trimellitic anhydride,C015559,trimellitic anhydride,https://ctdbase.org/detail.go?type=chem&acc=C015559,55024,BANK1,https://ctdbase.org/detail.go?type=gene&acc=55024,,,55024,BANK1,10090,Mus musculus (house mouse),Trimellitic anhydride results in increased expression of BANK1 mRNA,,,PMID:19042947,https://www.ncbi.nlm.nih.gov/pubmed/19042947,19042947,,
1,1092406,11089,Comparative Toxicogenomics Database (CTD),Trimellitic anhydride,C015559,trimellitic anhydride,https://ctdbase.org/detail.go?type=chem&acc=C015559,580,BARD1,https://ctdbase.org/detail.go?type=gene&acc=580,,,580,BARD1,10090,Mus musculus (house mouse),Trimellitic anhydride results in increased expression of BARD1 mRNA,,,PMID:19042947,https://www.ncbi.nlm.nih.gov/pubmed/19042947,19042947,,
2,1091059,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,388695,LYSMD1,https://ctdbase.org/detail.go?type=gene&acc=388695,,,388695,LYSMD1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of LYSMD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
3,1091060,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,17110,LYZ1,https://ctdbase.org/detail.go?type=gene&acc=17110,,,17110,Lyz1,10090,Mus musculus (house mouse),Bisphenol F results in decreased expression of LYZ1 protein|bisphenol F results in decreased expression of LYZ1 mRNA,,,PMID:35278557,https://www.ncbi.nlm.nih.gov/pubmed/35278557,35278557,,
4,1091061,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,17105,LYZ2,https://ctdbase.org/detail.go?type=gene&acc=17105,,,17105,Lyz2,10090,Mus musculus (house mouse),Bisphenol F results in increased expression of LYZ2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
5,1091762,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,9935,MAFB,https://ctdbase.org/detail.go?type=gene&acc=9935,,,9935,MAFB,10090,Mus musculus (house mouse),Bisphenol F results in decreased expression of MAFB mRNA,,,PMID:36674557,https://www.ncbi.nlm.nih.gov/pubmed/36674557,36674557,,
6,1091763,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,114463,MAFBB,https://ctdbase.org/detail.go?type=gene&acc=114463,,,114463,mafbb,7955,Danio rerio (zebrafish),Bisphenol F results in decreased expression of MAFBB mRNA,,,PMID:30265984,https://www.ncbi.nlm.nih.gov/pubmed/30265984,30265984,,
7,1091764,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,7975,MAFK,https://ctdbase.org/detail.go?type=gene&acc=7975,,,7975,MAFK,7955,Danio rerio (zebrafish),Bisphenol F results in decreased expression of MAFK mRNA,,,PMID:30265984,https://www.ncbi.nlm.nih.gov/pubmed/30265984,30265984,,
8,1091765,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,645864,MAGEB17,https://ctdbase.org/detail.go?type=gene&acc=645864,,,645864,MAGEB17,9606,Homo sapiens (human),Bisphenol F results in decreased expression of MAGEB17 mRNA,,,PMID:33476716,https://www.ncbi.nlm.nih.gov/pubmed/33476716,33476716,,
9,1091766,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,10916,MAGED2,https://ctdbase.org/detail.go?type=gene&acc=10916,,,10916,MAGED2,9606,Homo sapiens (human),Bisphenol F results in increased expression of MAGED2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
10,1091767,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,10916,MAGED2,https://ctdbase.org/detail.go?type=gene&acc=10916,,,10916,MAGED2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of MAGED2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
11,1091768,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,9863,MAGI2,https://ctdbase.org/detail.go?type=gene&acc=9863,,,9863,MAGI2,9606,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in decreased methylation of MAGI2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
12,1090415,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2897,GRIK1,https://ctdbase.org/detail.go?type=gene&acc=2897,,,2897,GRIK1,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of GRIK1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
13,1090416,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2899,GRIK3,https://ctdbase.org/detail.go?type=gene&acc=2899,,,2899,GRIK3,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of GRIK3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
14,1090417,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2900,GRIK4,https://ctdbase.org/detail.go?type=gene&acc=2900,,,2900,GRIK4,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in increased expression of GRIK4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
15,1090418,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2901,GRIK5,https://ctdbase.org/detail.go?type=gene&acc=2901,,,2901,GRIK5,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of GRIK5 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
16,1090419,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902,GRIN1,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of GRIN1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
17,1090420,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,2905,GRIN2C,https://ctdbase.org/detail.go?type=gene&acc=2905,,,2905,GRIN2C,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in increased expression of GRIN2C mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
18,1092575,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,11100,HNRNPUL1,https://ctdbase.org/detail.go?type=gene&acc=11100,,,11100,HNRNPUL1,10116,Rattus norvegicus (Norway rat),Nickel monoxide affects the expression of HNRNPUL1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
19,1092576,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,112817,HOGA1,https://ctdbase.org/detail.go?type=gene&acc=112817,,,112817,HOGA1,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of HOGA1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
20,1092577,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,84525,HOPX,https://ctdbase.org/detail.go?type=gene&acc=84525,,,84525,HOPX,10116,Rattus norvegicus (Norway rat),Nickel monoxide results in decreased expression of HOPX mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
21,1092578,14805,Comparative Toxicogenomics Database (CTD),Nickel oxide,C028007,nickel monoxide,https://ctdbase.org/detail.go?type=chem&acc=C028007,100506311,HOTAIRM1,https://ctdbase.org/detail.go?type=gene&acc=100506311,,,100506311,HOTAIRM1,9606,Homo sapiens (human),HOTAIRM1 protein inhibits the reaction [nickel monoxide results in increased expression of and results in increased phosphorylation of JUN protein]|hotairm1 protein inhibits the reaction [nickel monoxide results in increased expression of and results in increased phosphorylation of MAPK8 protein]|nickel monoxide results in decreased expression of HOTAIRM1 mrna|hotairm1 protein inhibits the reaction [nickel monoxide results in decreased methylation of PRKCB promoter],,,PMID:36066426,https://www.ncbi.nlm.nih.gov/pubmed/36066426,36066426,,
22,1090911,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,8666,EIF3G,https://ctdbase.org/detail.go?type=gene&acc=8666,,,8666,EIF3G,9606,Homo sapiens (human),Cupric oxide affects the phosphorylation of EIF3G protein,,,PMID:25470785,https://www.ncbi.nlm.nih.gov/pubmed/25470785,25470785,,
23,1090912,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,51386,EIF3L,https://ctdbase.org/detail.go?type=gene&acc=51386,,,51386,EIF3L,9606,Homo sapiens (human),Cupric oxide results in increased expression of EIF3L protein,,,PMID:25470785,https://www.ncbi.nlm.nih.gov/pubmed/25470785,25470785,,
24,1090913,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,7458,EIF4H,https://ctdbase.org/detail.go?type=gene&acc=7458,,,7458,EIF4H,9606,Homo sapiens (human),Cupric oxide results in increased expression of EIF4H protein,,,PMID:25470785,https://www.ncbi.nlm.nih.gov/pubmed/25470785,25470785,,
25,1090914,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,1984,EIF5A,https://ctdbase.org/detail.go?type=gene&acc=1984,,,1984,EIF5A,10090,Mus musculus (house mouse),Cupric oxide analog results in decreased expression of EIF5A protein,,,PMID:23882024,https://www.ncbi.nlm.nih.gov/pubmed/23882024,23882024,,
26,1090915,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,9669,EIF5B,https://ctdbase.org/detail.go?type=gene&acc=9669,,,9669,EIF5B,9606,Homo sapiens (human),Cupric oxide results in decreased phosphorylation of EIF5B protein,,,PMID:25470785,https://www.ncbi.nlm.nih.gov/pubmed/25470785,25470785,,
27,1090916,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,8178,ELL,https://ctdbase.org/detail.go?type=gene&acc=8178,,,8178,ELL,9606,Homo sapiens (human),Cupric oxide results in increased expression of ELL mRNA,,,PMID:22077320,https://www.ncbi.nlm.nih.gov/pubmed/22077320,22077320,,
28,1090917,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,2048,EPHB2,https://ctdbase.org/detail.go?type=gene&acc=2048,,,2048,EPHB2,9606,Homo sapiens (human),Cupric oxide results in decreased expression of EPHB2 mRNA,,,PMID:22077320,https://www.ncbi.nlm.nih.gov/pubmed/22077320,22077320,,
29,1090918,14829,Comparative Toxicogenomics Database (CTD),Copper oxide (CuO),C030973,cupric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030973,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052,EPHX1,9606,Homo sapiens (human),Cupric oxide results in decreased expression of EPHX1 mRNA,,,PMID:32285662,https://www.ncbi.nlm.nih.gov/pubmed/32285662,32285662,,
30,1092726,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306,ANXA3,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of ANXA3 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
31,1092727,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306,ANXA3,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in decreased expression of ANXA3 mRNA,,,PMID:15667827,https://www.ncbi.nlm.nih.gov/pubmed/15667827,15667827,,
32,1092728,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306,ANXA3,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin affects the expression of ANXA3 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
33,1092729,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306,ANXA3,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of ANXA3 mRNA,,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
34,1092730,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307,ANXA4,9606,Homo sapiens (human),Tetrachlorodibenzodioxin results in increased expression of ANXA4 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
35,1092731,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307,ANXA4,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of ANXA4 mRNA,,,PMID:18343893|PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/18343893|https://www.ncbi.nlm.nih.gov/pubmed/21570461,18343893|21570461,,
36,1092732,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307,ANXA4,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in decreased expression of ANXA4 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
37,1092733,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307,ANXA4,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of ANXA4 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
38,1092734,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307,ANXA4,10116,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of ANXA4 mRNA,,,PMID:21215274,https://www.ncbi.nlm.nih.gov/pubmed/21215274,21215274,,
39,1089967,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,84129,ACAD11,https://ctdbase.org/detail.go?type=gene&acc=84129,,,84129,ACAD11,7955,Danio rerio (zebrafish),Dronabinol affects the expression of ACAD11 mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
40,1089968,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,27034,ACAD8,https://ctdbase.org/detail.go?type=gene&acc=27034,,,27034,ACAD8,10116,Rattus norvegicus (Norway rat),Dronabinol results in increased expression of ACAD8 mrna|[dronabinol co-treated with ethanol] results in increased expression of ACAD8 mRNA,,,PMID:17618662,https://www.ncbi.nlm.nih.gov/pubmed/17618662,17618662,,
41,1089969,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34,ACADM,7955,Danio rerio (zebrafish),Dronabinol affects the expression of ACADM mRNA,,,PMID:33892503,https://www.ncbi.nlm.nih.gov/pubmed/33892503,33892503,,
42,1089970,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38,ACAT1,10116,Rattus norvegicus (Norway rat),Dronabinol results in increased expression of ACAT1 mRNA,,,PMID:30283037,https://www.ncbi.nlm.nih.gov/pubmed/30283037,30283037,,
43,1089971,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,217246,ACE3,https://ctdbase.org/detail.go?type=gene&acc=217246,,,217246,Ace3,10116,Rattus norvegicus (Norway rat),Dronabinol affects the methylation of ACE3 gene,,,PMID:26044905,https://www.ncbi.nlm.nih.gov/pubmed/26044905,26044905,,
44,1089972,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,55331,ACER3,https://ctdbase.org/detail.go?type=gene&acc=55331,,,55331,ACER3,10116,Rattus norvegicus (Norway rat),Dronabinol results in decreased expression of ACER3 mRNA,,,PMID:30283037,https://www.ncbi.nlm.nih.gov/pubmed/30283037,30283037,,
45,1089973,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43,ACHE,10116,Rattus norvegicus (Norway rat),[plant extracts results in increased abundance of dronabinol] inhibits the reaction [reserpine affects the activity of ACHE protein],,,PMID:28212939,https://www.ncbi.nlm.nih.gov/pubmed/28212939,28212939,,
46,1092106,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,79026,AHNAK,https://ctdbase.org/detail.go?type=gene&acc=79026,,,79026,AHNAK,10116,Rattus norvegicus (Norway rat),Dronabinol affects the methylation of AHNAK gene,,,PMID:26044905,https://www.ncbi.nlm.nih.gov/pubmed/26044905,26044905,,
47,1092894,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,9606,Homo sapiens (human),SR 144528 inhibits the reaction [dronabinol results in decreased phosphorylation of AKT1 protein]|erbb2 protein affects the reaction [dronabinol results in decreased phosphorylation of AKT1 protein],,,PMID:30733293,https://www.ncbi.nlm.nih.gov/pubmed/30733293,30733293,,
48,1092895,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,9606,Homo sapiens (human),MDK inhibits the reaction [dronabinol results in decreased phosphorylation of AKT1 protein],,,PMID:21233844,https://www.ncbi.nlm.nih.gov/pubmed/21233844,21233844,,
49,1092896,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,10090,Mus musculus (house mouse),CNR2 protein affects the reaction [dronabinol affects the phosphorylation of AKT1 protein]|dronabinol affects the phosphorylation of AKT1 protein|cnr1 protein affects the reaction [dronabinol affects the phosphorylation of AKT1 protein],,,PMID:31436397,https://www.ncbi.nlm.nih.gov/pubmed/31436397,31436397,,
50,1092897,16078,Comparative Toxicogenomics Database (CTD),Dronabinol,D013759,Dronabinol,https://ctdbase.org/detail.go?type=chem&acc=D013759,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,10090,Mus musculus (house mouse),Dronabinol results in increased phosphorylation of AKT1 protein,,,PMID:32956517,https://www.ncbi.nlm.nih.gov/pubmed/32956517,32956517,,
51,1090263,16363,IUPHAR/BPS Guide to PHARMACOLOGY,Benperidol,9215,benperidol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9215,215,D2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=215,P14416,D(2) dopamine receptor,1813,DRD2,9606,Homo sapiens (human),Antagonist,pKi,10.57,PMID:9577836,https://www.ncbi.nlm.nih.gov/pubmed/9577836,9577836,,
52,1090264,16441,Therapeutic Target Database (TTD),Perillaldehyde,D00AVT,Perillaldehyde,https://idrblab.net/ttd/data/drug/details/D00AVT,T41955,Long transient receptor potential channel 8 (TRPM8),https://idrblab.net/ttd/data/target/details/T41955,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,79054,TRPM8,9606,Homo sapiens (human),Inhibitor,,,,,,,
53,1090265,16533,Drug Gene Interaction database (DGIdb),Betamethasone Valerate,,BETAMETHASONE VALERATE,https://www.dgidb.org/drugs/rxcui:227897,,AR,https://www.dgidb.org/genes/hgnc:644,,,367,AR,9606,Homo sapiens (human),,,,,,,,
54,1090266,16666,Drug Gene Interaction database (DGIdb),l-Menthol,,RACEMENTHOL,https://www.dgidb.org/drugs/rxcui:1430390,,TRPM8,https://www.dgidb.org/genes/hgnc:17961,,,79054,TRPM8,9606,Homo sapiens (human),,,,,,,,
55,1090267,16666,Drug Gene Interaction database (DGIdb),l-Menthol,,RACEMENTHOL,https://www.dgidb.org/drugs/rxcui:1430390,,TRPV3,https://www.dgidb.org/genes/hgnc:18084,,,162514,TRPV3,9606,Homo sapiens (human),,,,,,,,
56,1090268,16666,Drug Gene Interaction database (DGIdb),l-Menthol,,RACEMENTHOL,https://www.dgidb.org/drugs/rxcui:1430390,,TRPM8,https://www.dgidb.org/genes/hgnc:17961,,,79054,TRPM8,9606,Homo sapiens (human),,,,,,,,
57,1090269,16666,Toxin and Toxin Target Database (T3DB),l-Menthol,T3D3224,Menthol,http://www.t3db.ca/toxins/T3D3224,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989,TRPA1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:12654248|PMID:15931068|PMID:16829128,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/12654248|https://www.ncbi.nlm.nih.gov/pubmed/15931068|https://www.ncbi.nlm.nih.gov/pubmed/16829128,11752352|12654248|15931068|16829128,,
58,1090270,16666,Toxin and Toxin Target Database (T3DB),l-Menthol,T3D3224,Menthol,http://www.t3db.ca/toxins/T3D3224,BE0001186,Transient receptor potential cation channel subfamily M member 8,http://www.t3db.ca/biodb/bio_entities/BE0001186,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,79054,TRPM8,9606,Homo sapiens (human),Menthol is a TRPM8 agonist (A349).,,,PMID:18060696|PMID:17293875|PMID:17517434,https://www.ncbi.nlm.nih.gov/pubmed/18060696|https://www.ncbi.nlm.nih.gov/pubmed/17293875|https://www.ncbi.nlm.nih.gov/pubmed/17517434,18060696|17293875|17517434,,
59,1090753,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,8563,THOC5,https://ctdbase.org/detail.go?type=gene&acc=8563,,,8563,THOC5,9606,Homo sapiens (human),Beta-methylcholine affects the expression of THOC5 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
60,1090754,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,7072,TIA1,https://ctdbase.org/detail.go?type=gene&acc=7072,,,7072,TIA1,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TIA1 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
61,1090755,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,7073,TIAL1,https://ctdbase.org/detail.go?type=gene&acc=7073,,,7073,TIAL1,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TIAL1 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
62,1090756,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,26230,TIAM2,https://ctdbase.org/detail.go?type=gene&acc=26230,,,26230,TIAM2,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TIAM2 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
63,1090757,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,148022,TICAM1,https://ctdbase.org/detail.go?type=gene&acc=148022,,,148022,TICAM1,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TICAM1 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
64,1090758,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520,TIMM9,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TIMM9 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
65,1090759,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,261726,TIPRL,https://ctdbase.org/detail.go?type=gene&acc=261726,,,261726,TIPRL,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TIPRL mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
66,1090760,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083,TK1,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TK1 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
67,1090761,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,79850,TLCD3A,https://ctdbase.org/detail.go?type=gene&acc=79850,,,79850,TLCD3A,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TLCD3A mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
68,1090762,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,80213,TM2D3,https://ctdbase.org/detail.go?type=gene&acc=80213,,,80213,TM2D3,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TM2D3 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
69,1092097,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,7726,TRIM26,https://ctdbase.org/detail.go?type=gene&acc=7726,,,7726,TRIM26,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM26 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
70,1092098,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,22954,TRIM32,https://ctdbase.org/detail.go?type=gene&acc=22954,,,22954,TRIM32,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM32 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
71,1092099,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,56658,TRIM39,https://ctdbase.org/detail.go?type=gene&acc=56658,,,56658,TRIM39,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM39 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
72,1092100,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,89122,TRIM4,https://ctdbase.org/detail.go?type=gene&acc=89122,,,89122,TRIM4,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM4 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
73,1092101,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,80128,TRIM46,https://ctdbase.org/detail.go?type=gene&acc=80128,,,80128,TRIM46,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM46 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
74,1092102,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,84851,TRIM52,https://ctdbase.org/detail.go?type=gene&acc=84851,,,84851,TRIM52,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIM52 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
75,1092103,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,7204,TRIO,https://ctdbase.org/detail.go?type=gene&acc=7204,,,7204,TRIO,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIO mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
76,1092104,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,11078,TRIOBP,https://ctdbase.org/detail.go?type=gene&acc=11078,,,11078,TRIOBP,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIOBP mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
77,1092105,16942,Comparative Toxicogenomics Database (CTD),2-Methylcholine,C044887,beta-methylcholine,https://ctdbase.org/detail.go?type=chem&acc=C044887,9321,TRIP11,https://ctdbase.org/detail.go?type=gene&acc=9321,,,9321,TRIP11,9606,Homo sapiens (human),Beta-methylcholine affects the expression of TRIP11 mRNA,,,PMID:21179406,https://www.ncbi.nlm.nih.gov/pubmed/21179406,21179406,,
78,1090571,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,146206,CARMIL2,https://ctdbase.org/detail.go?type=gene&acc=146206,,,146206,CARMIL2,9606,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of CARMIL2 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
79,1090572,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,833,CARS1,https://ctdbase.org/detail.go?type=gene&acc=833,,,833,CARS1,9606,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of CARS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
80,1090573,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,401237,CASC15,https://ctdbase.org/detail.go?type=gene&acc=401237,,,401237,CASC15,9606,Homo sapiens (human),Aflatoxin B2 affects the methylation of CASC15 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
81,1090118,24549,Toxin and Toxin Target Database (T3DB),Lead fluoride,T3D1327,Lead fluoride,http://www.t3db.ca/toxins/T3D1327,BE0005018,Sodium/potassium-transporting ATPase subunit beta-2,http://www.t3db.ca/biodb/bio_entities/BE0005018,P14415,Sodium/potassium-transporting ATPase subunit beta-2,482,ATP1B2,9606,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
82,1090119,24549,Toxin and Toxin Target Database (T3DB),Lead fluoride,T3D1327,Lead fluoride,http://www.t3db.ca/toxins/T3D1327,BE0005026,Sodium/potassium-transporting ATPase subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0005026,P54709,Sodium/potassium-transporting ATPase subunit beta-3,483,ATP1B3,9606,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
83,1090120,24549,Toxin and Toxin Target Database (T3DB),Lead fluoride,T3D1327,Lead fluoride,http://www.t3db.ca/toxins/T3D1327,BE0000229,Sodium/potassium-transporting ATPase subunit gamma,http://www.t3db.ca/biodb/bio_entities/BE0000229,P54710,Sodium/potassium-transporting ATPase subunit gamma,486,FXYD2,9606,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
84,1090121,24549,Toxin and Toxin Target Database (T3DB),Lead fluoride,T3D1327,Lead fluoride,http://www.t3db.ca/toxins/T3D1327,BE0005042,Thymosin beta-4,http://www.t3db.ca/biodb/bio_entities/BE0005042,P62328,Thymosin beta-4,7114,TMSB4X,9606,Homo sapiens (human),"Lead has been shown to bind thymosin beta-4, which functions in the modulation of cytoskeletion, stimulation of cam-dependent kinases, and GABA-A receptor complex function. it is also an immunotransmitter. (A21)",,,PMID:9817074,https://www.ncbi.nlm.nih.gov/pubmed/9817074,9817074,,
85,1090909,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,220929,ZNF438,https://ctdbase.org/detail.go?type=gene&acc=220929,,,220929,ZNF438,9606,Homo sapiens (human),Potassium chromate(vi) results in decreased expression of ZNF438 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZNF438 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
86,1090910,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,79973,ZNF442,https://ctdbase.org/detail.go?type=gene&acc=79973,,,79973,ZNF442,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ZNF442 mrna|potassium chromate(vi) results in increased expression of ZNF442 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
87,1091545,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,58492,ZNF77,https://ctdbase.org/detail.go?type=gene&acc=58492,,,58492,ZNF77,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of ZNF77 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ZNF77 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
88,1091546,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,197320,ZNF778,https://ctdbase.org/detail.go?type=gene&acc=197320,,,197320,ZNF778,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of ZNF778 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
89,1091547,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,388507,ZNF788P,https://ctdbase.org/detail.go?type=gene&acc=388507,,,388507,ZNF788P,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of ZNF788P mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
90,1091548,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,163049,ZNF791,https://ctdbase.org/detail.go?type=gene&acc=163049,,,163049,ZNF791,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of ZNF791 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ZNF791 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
91,1091549,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,91752,ZNF804A,https://ctdbase.org/detail.go?type=gene&acc=91752,,,91752,ZNF804A,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZNF804A mrna|potassium chromate(vi) results in decreased expression of ZNF804A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
92,1091550,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,91752,ZNF804A,https://ctdbase.org/detail.go?type=gene&acc=91752,,,91752,ZNF804A,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of ZNF804A mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
93,1091551,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,152485,ZNF827,https://ctdbase.org/detail.go?type=gene&acc=152485,,,152485,ZNF827,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZNF827 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
94,1091552,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,152485,ZNF827,https://ctdbase.org/detail.go?type=gene&acc=152485,,,152485,ZNF827,9606,Homo sapiens (human),Potassium chromate(vi) results in decreased expression of ZNF827 mRNA,,,PMID:22079256|PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22079256|https://www.ncbi.nlm.nih.gov/pubmed/22714537,22079256|22714537,,
95,1091914,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,5917,RARS1,https://ctdbase.org/detail.go?type=gene&acc=5917,,,5917,RARS1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of RARS1 mrna|potassium chromate(vi) results in decreased expression of RARS1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
96,1091915,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,5921,RASA1,https://ctdbase.org/detail.go?type=gene&acc=5921,,,5921,RASA1,9606,Homo sapiens (human),Potassium chromate(vi) results in decreased expression of RASA1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
97,1091916,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,9462,RASAL2,https://ctdbase.org/detail.go?type=gene&acc=9462,,,9462,RASAL2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of RASAL2 mrna|potassium chromate(vi) results in decreased expression of RASAL2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
98,1091917,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,10125,RASGRP1,https://ctdbase.org/detail.go?type=gene&acc=10125,,,10125,RASGRP1,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of RASGRP1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
99,1091918,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,25780,RASGRP3,https://ctdbase.org/detail.go?type=gene&acc=25780,,,25780,RASGRP3,9606,Homo sapiens (human),Potassium chromate(vi) results in decreased expression of RASGRP3 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of RASGRP3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
100,1091919,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,25780,RASGRP3,https://ctdbase.org/detail.go?type=gene&acc=25780,,,25780,RASGRP3,9606,Homo sapiens (human),Potassium chromate(vi) results in increased expression of RASGRP3 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
101,1091920,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,387496,RASL11A,https://ctdbase.org/detail.go?type=gene&acc=387496,,,387496,RASL11A,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mrna|potassium chromate(vi) results in increased expression of RASL11A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
102,1091921,24597,Comparative Toxicogenomics Database (CTD),Potassium Chromate,C027373,potassium chromate(VI),https://ctdbase.org/detail.go?type=chem&acc=C027373,11228,RASSF8,https://ctdbase.org/detail.go?type=gene&acc=11228,,,11228,RASSF8,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of RASSF8 mrna|potassium chromate(vi) results in decreased expression of RASSF8 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
103,1090574,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337,DNAJB1,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of DNAJB1 mRNA,,,PMID:23557971|PMID:27760801|PMID:29128614|PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/23557971|https://www.ncbi.nlm.nih.gov/pubmed/27760801|https://www.ncbi.nlm.nih.gov/pubmed/29128614|https://www.ncbi.nlm.nih.gov/pubmed/29264374,23557971|27760801|29128614|29264374,,
104,1090575,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337,DNAJB1,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of DNAJB1 mRNA,,,PMID:23409001|PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/31298478,23409001|31298478,,
105,1090576,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337,DNAJB1,10116,Rattus norvegicus (Norway rat),Titanium dioxide results in decreased expression of DNAJB1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
106,1090577,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51726,DNAJB11,https://ctdbase.org/detail.go?type=gene&acc=51726,,,51726,DNAJB11,9606,Homo sapiens (human),Titanium dioxide results in decreased expression of DNAJB11 protein,,,PMID:30910687,https://www.ncbi.nlm.nih.gov/pubmed/30910687,30910687,,
107,1090578,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51726,DNAJB11,https://ctdbase.org/detail.go?type=gene&acc=51726,,,51726,DNAJB11,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of DNAJB11 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
108,1090579,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,54788,DNAJB12,https://ctdbase.org/detail.go?type=gene&acc=54788,,,54788,DNAJB12,9606,Homo sapiens (human),Titanium dioxide results in decreased methylation of DNAJB12 gene,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
109,1090580,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,414061,DNAJB3,https://ctdbase.org/detail.go?type=gene&acc=414061,,,414061,DNAJB3,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of DNAJB3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
110,1091544,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843,DUSP1,10116,Rattus norvegicus (Norway rat),Titanium dioxide results in decreased expression of DUSP1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
111,1092407,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,60401,EDA2R,https://ctdbase.org/detail.go?type=gene&acc=60401,,,60401,EDA2R,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of EDA2R mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
112,1092408,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,23644,EDC4,https://ctdbase.org/detail.go?type=gene&acc=23644,,,23644,EDC4,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of EDC4 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
113,1092409,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,10085,EDIL3,https://ctdbase.org/detail.go?type=gene&acc=10085,,,10085,EDIL3,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of EDIL3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
114,1092410,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906,EDN1,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of EDN1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
115,1092411,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906,EDN1,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of EDN1 mRNA,,,PMID:23409001|PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/23557971,23409001|23557971,,
116,1092412,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907,EDN2,10090,Mus musculus (house mouse),Titanium dioxide affects the expression of EDN2 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
117,1092413,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907,EDN2,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of EDN2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
118,1092414,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909,EDNRA,10090,Mus musculus (house mouse),Titanium dioxide affects the expression of EDNRA mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
119,1305451,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,55904,KMT2E,https://ctdbase.org/detail.go?type=gene&acc=55904,,,55904,KMT2E,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of KMT2E mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
120,1305452,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082,KNL1,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of KNL1 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
121,1090113,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,84684,INSM2,https://ctdbase.org/detail.go?type=gene&acc=84684,,,84684,INSM2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INSM2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
122,1090114,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643,INSR,10090,Mus musculus (house mouse),"[tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylhexyl phthalate co-treated with bisphenol A] results in increased expression of INSR mRNA",,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
123,1090115,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,245699,INSRA,https://ctdbase.org/detail.go?type=gene&acc=245699,,,245699,insra,7955,Danio rerio (zebrafish),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of INSRA mRNA",,,PMID:31621872,https://www.ncbi.nlm.nih.gov/pubmed/31621872,31621872,,
124,1090116,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,245700,INSRB,https://ctdbase.org/detail.go?type=gene&acc=245700,,,245700,insrb,7955,Danio rerio (zebrafish),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of INSRB mRNA",,,PMID:31621872,https://www.ncbi.nlm.nih.gov/pubmed/31621872,31621872,,
125,1090117,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,54973,INTS11,https://ctdbase.org/detail.go?type=gene&acc=54973,,,54973,INTS11,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INTS11 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
126,1319334,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,10100,TSPAN2,https://ctdbase.org/detail.go?type=gene&acc=10100,,,10100,TSPAN2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSPAN2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
127,1319335,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,54084,TSPEAR,https://ctdbase.org/detail.go?type=gene&acc=54084,,,54084,TSPEAR,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSPEAR mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
128,1089834,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,3839,KPNA3,https://ctdbase.org/detail.go?type=gene&acc=3839,,,3839,KPNA3,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of KPNA3 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
129,1089964,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,55323,LARP6,https://ctdbase.org/detail.go?type=gene&acc=55323,,,55323,LARP6,9606,Homo sapiens (human),LARP6 protein affects the susceptibility to topotecan,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
130,1089965,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,27040,LAT,https://ctdbase.org/detail.go?type=gene&acc=27040,,,27040,LAT,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in increased expression of LAT mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
131,1089966,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,26524,LATS2,https://ctdbase.org/detail.go?type=gene&acc=26524,,,26524,LATS2,10116,Rattus norvegicus (Norway rat),Topotecan results in increased expression of LATS2 mrna|[oxaliplatin co-treated with topotecan] results in increased expression of LATS2 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
132,1091922,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255,MGMT,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in increased expression of MGMT mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
133,1092579,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,740,MRPL49,https://ctdbase.org/detail.go?type=gene&acc=740,,,740,MRPL49,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MRPL49 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
134,1092580,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,54534,MRPL50,https://ctdbase.org/detail.go?type=gene&acc=54534,,,54534,MRPL50,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MRPL50 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
135,1092581,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,51258,MRPL51,https://ctdbase.org/detail.go?type=gene&acc=51258,,,51258,MRPL51,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MRPL51 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
136,1092582,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,78988,MRPL57,https://ctdbase.org/detail.go?type=gene&acc=78988,,,78988,MRPL57,9606,Homo sapiens (human),MRPL57 protein affects the susceptibility to topotecan,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
137,1092583,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,64960,MRPS15,https://ctdbase.org/detail.go?type=gene&acc=64960,,,64960,MRPS15,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MRPS15 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
138,1092584,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,51023,MRPS18C,https://ctdbase.org/detail.go?type=gene&acc=51023,,,51023,MRPS18C,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MRPS18C mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
139,1092725,60700,Comparative Toxicogenomics Database (CTD),Topotecan,D019772,Topotecan,https://ctdbase.org/detail.go?type=chem&acc=D019772,124540,MSI2,https://ctdbase.org/detail.go?type=gene&acc=124540,,,124540,MSI2,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of MSI2 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
140,1090411,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,9514,GAL3ST1,https://ctdbase.org/detail.go?type=gene&acc=9514,,,9514,GAL3ST1,9606,Homo sapiens (human),Gemcitabine results in decreased expression of GAL3ST1 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
141,1090412,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,2619,GAS1,https://ctdbase.org/detail.go?type=gene&acc=2619,,,2619,GAS1,9606,Homo sapiens (human),Gemcitabine results in decreased expression of GAS1 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
142,1090413,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,9518,GDF15,https://ctdbase.org/detail.go?type=gene&acc=9518,,,9518,GDF15,9606,Homo sapiens (human),[gemcitabine co-treated with erlotinib hydrochloride] affects the expression of GDF15 protein,,,PMID:24979617,https://www.ncbi.nlm.nih.gov/pubmed/24979617,24979617,,
143,1090414,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,10755,GIPC1,https://ctdbase.org/detail.go?type=gene&acc=10755,,,10755,GIPC1,9606,Homo sapiens (human),GIPC1 affects the susceptibility to gemcitabine,,,PMID:25469510,https://www.ncbi.nlm.nih.gov/pubmed/25469510,25469510,,
144,1091062,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,8826,IQGAP1,https://ctdbase.org/detail.go?type=gene&acc=8826,,,8826,IQGAP1,9606,Homo sapiens (human),Gemcitabine results in increased expression of IQGAP1 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
145,1091063,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,3656,IRAK2,https://ctdbase.org/detail.go?type=gene&acc=3656,,,3656,IRAK2,9606,Homo sapiens (human),Gemcitabine results in increased expression of IRAK2 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
146,1091064,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,3661,IRF3,https://ctdbase.org/detail.go?type=gene&acc=3661,,,3661,IRF3,9606,Homo sapiens (human),Gemcitabine results in decreased expression of IRF3 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
147,1091065,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,3685,ITGAV,https://ctdbase.org/detail.go?type=gene&acc=3685,,,3685,ITGAV,9606,Homo sapiens (human),[ITGB6 co-treated with ITGAV] affects the susceptibility to gemcitabine,,,PMID:20150628,https://www.ncbi.nlm.nih.gov/pubmed/20150628,20150628,,
148,1091066,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,3694,ITGB6,https://ctdbase.org/detail.go?type=gene&acc=3694,,,3694,ITGB6,9606,Homo sapiens (human),[ITGB6 co-treated with ITGAV] affects the susceptibility to gemcitabine,,,PMID:20150628,https://www.ncbi.nlm.nih.gov/pubmed/20150628,20150628,,
149,1091067,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,50618,ITSN2,https://ctdbase.org/detail.go?type=gene&acc=50618,,,50618,ITSN2,9606,Homo sapiens (human),Gemcitabine results in increased expression of ITSN2 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
150,1091068,60749,Comparative Toxicogenomics Database (CTD),Gemcitabine Hydrochloride,D000093542,Gemcitabine,https://ctdbase.org/detail.go?type=chem&acc=D000093542,83700,JAM3,https://ctdbase.org/detail.go?type=gene&acc=83700,,,83700,JAM3,9606,Homo sapiens (human),Gemcitabine results in decreased expression of JAM3 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
151,1091210,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,SLC29A1,https://www.dgidb.org/genes/hgnc:11003,,,2030,SLC29A1,9606,Homo sapiens (human),,,,,,,,
152,1091211,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,XRCC1,https://www.dgidb.org/genes/hgnc:12828,,,7515,XRCC1,9606,Homo sapiens (human),,,,,,,,
153,1091212,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,KRAS,https://www.dgidb.org/genes/hgnc:6407,,,3845,KRAS,9606,Homo sapiens (human),,,,,,,,
154,1091213,60750,Drug Gene Interaction database (DGIdb),Gemcitabine,,GEMCITABINE,https://www.dgidb.org/drugs/rxcui:12574,,BRCA2,https://www.dgidb.org/genes/hgnc:1101,,,675,BRCA2,9606,Homo sapiens (human),,,,,,,,
155,1091379,60812,Therapeutic Target Database (TTD),Lesopitron dihydrochloride,D0G5TU,LESOPITRON DIHYDROCHLORIDE,https://idrblab.net/ttd/data/drug/details/D0G5TU,T78709,5-HT 1A receptor (HTR1A),https://idrblab.net/ttd/data/target/details/T78709,P08908,5-hydroxytryptamine receptor 1A,3350,HTR1A,9606,Homo sapiens (human),Agonist,,,,,,,
156,1092259,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,HTR1B,https://www.dgidb.org/genes/hgnc:5287,,,3351,HTR1B,9606,Homo sapiens (human),,,,,,,,
157,1092260,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532,SLC6A4,9606,Homo sapiens (human),,,,,,,,
158,1092261,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,AANAT,https://www.dgidb.org/genes/hgnc:19,,,15,AANAT,9606,Homo sapiens (human),,,,,,,,
159,1092262,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,GSK3B,https://www.dgidb.org/genes/hgnc:4617,,,2932,GSK3B,9606,Homo sapiens (human),,,,,,,,
160,1092263,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,ACE,https://www.dgidb.org/genes/hgnc:2707,,,1636,ACE,9606,Homo sapiens (human),,,,,,,,
161,1092264,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,SLC6A4,https://www.dgidb.org/genes/hgnc:11050,,,6532,SLC6A4,9606,Homo sapiens (human),,,,,,,,
162,1092265,62857,Drug Gene Interaction database (DGIdb),Fluoxetine Hydrochloride,,FLUOXETINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:227224,,REEP5,https://www.dgidb.org/genes/hgnc:30077,,,7905,REEP5,9606,Homo sapiens (human),,,,,,,,
163,1092266,62884,Drug Gene Interaction database (DGIdb),Bupropion Hydrochloride,,BUPROPION HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203204,,SACM1L,https://www.dgidb.org/genes/hgnc:17059,,,22908,SACM1L,9606,Homo sapiens (human),,,,,,,,
164,1092267,62884,Drug Gene Interaction database (DGIdb),Bupropion Hydrochloride,,BUPROPION HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203204,,COMT,https://www.dgidb.org/genes/hgnc:2228,,,1312,COMT,9606,Homo sapiens (human),,,,,,,,
165,1091380,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,146547,PRSS36,https://ctdbase.org/detail.go?type=gene&acc=146547,,,146547,PRSS36,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of PRSS36 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
166,1091381,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968,PSAT1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of PSAT1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
167,1091382,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699,PSMB10,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of PSMB10 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
168,1091383,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695,PSMB7,8022,Oncorhynchus mykiss (rainbow trout),Perfluoro-n-nonanoic acid results in increased expression of PSMB7 mRNA,,,PMID:21984479,https://www.ncbi.nlm.nih.gov/pubmed/21984479,21984479,,
169,1091384,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698,PSMB9,8022,Oncorhynchus mykiss (rainbow trout),Perfluoro-n-nonanoic acid results in increased expression of PSMB9 mRNA,,,PMID:21984479,https://www.ncbi.nlm.nih.gov/pubmed/21984479,21984479,,
170,1091385,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,5721,PSME2,https://ctdbase.org/detail.go?type=gene&acc=5721,,,5721,PSME2,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of PSME2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
171,1091386,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,5723,PSPH,https://ctdbase.org/detail.go?type=gene&acc=5723,,,5723,PSPH,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of PSPH mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
172,1091387,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,571331,PSTPIP1A,https://ctdbase.org/detail.go?type=gene&acc=571331,,,571331,pstpip1a,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PSTPIP1A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
173,1091388,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,100005416,PTGER4B,https://ctdbase.org/detail.go?type=gene&acc=100005416,,,100005416,ptger4b,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PTGER4B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
174,1091759,67822,Comparative Toxicogenomics Database (CTD),Perfluorotetradecanoic acid,C000720111,perfluorotetradecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C000720111,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246,ALOX15,10116,Rattus norvegicus (Norway rat),Perfluorotetradecanoic acid results in increased expression of ALOX15 mrna|perfluorotetradecanoic acid results in increased expression of ALOX15 protein,,,PMID:37269911,https://www.ncbi.nlm.nih.gov/pubmed/37269911,37269911,,
175,1091760,67822,Comparative Toxicogenomics Database (CTD),Perfluorotetradecanoic acid,C000720111,perfluorotetradecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C000720111,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338,APOB,9606,Homo sapiens (human),Perfluorotetradecanoic acid results in decreased expression of APOB mRNA,,,PMID:36251517,https://www.ncbi.nlm.nih.gov/pubmed/36251517,36251517,,
176,1091761,67822,Comparative Toxicogenomics Database (CTD),Perfluorotetradecanoic acid,C000720111,perfluorotetradecanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C000720111,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,9606,Homo sapiens (human),Perfluorotetradecanoic acid results in increased expression of ATF4 mRNA,,,PMID:36251517,https://www.ncbi.nlm.nih.gov/pubmed/36251517,36251517,,
177,1357476,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721,SREBF2,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of SREBF2 mRNA,,,PMID:32253466,https://www.ncbi.nlm.nih.gov/pubmed/32253466,32253466,,
178,1090261,104894,Toxin and Toxin Target Database (T3DB),Antimony cation (3+),T3D0219,Antimony,http://www.t3db.ca/toxins/T3D0219,BE0002282,Microsomal glutathione S-transferase 1,http://www.t3db.ca/biodb/bio_entities/BE0002282,P10620,Microsomal glutathione S-transferase 1,4257,MGST1,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
179,1090262,104894,Toxin and Toxin Target Database (T3DB),Antimony cation (3+),T3D0219,Antimony,http://www.t3db.ca/toxins/T3D0219,BE0002290,Microsomal glutathione S-transferase 2,http://www.t3db.ca/biodb/bio_entities/BE0002290,Q99735,Microsomal glutathione S-transferase 2,4258,MGST2,9606,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
180,1091214,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467,ATF3,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of ATF3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
181,1091215,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,9606,Homo sapiens (human),Glucose deficiency results in increased expression of ATF4 protein|4-quinolones analog inhibits the reaction [glucose deficiency results in increased expression of ATF4 protein]|salubrinal inhibits the reaction [4-quinolones analog inhibits the reaction [glucose deficiency results in increased expression of ATF4 protein]],,,PMID:31022492,https://www.ncbi.nlm.nih.gov/pubmed/31022492,31022492,,
182,1091216,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,9606,Homo sapiens (human),ATF4 protein results in increased susceptibility to glucose,,,PMID:27278863,https://www.ncbi.nlm.nih.gov/pubmed/27278863,27278863,,
183,1091217,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,9606,Homo sapiens (human),[galactose co-treated with glucose deficiency] promotes the reaction [leflunomide results in increased expression of ATF4 protein],,,PMID:29427785,https://www.ncbi.nlm.nih.gov/pubmed/29427785,29427785,,
184,1091218,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,10090,Mus musculus (house mouse),Glucose deficiency results in increased expression of ATF4 mRNA,,,PMID:27226639,https://www.ncbi.nlm.nih.gov/pubmed/27226639,27226639,,
185,1091219,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468,ATF4,10116,Rattus norvegicus (Norway rat),Chlorogenic acid inhibits the reaction [glucose results in increased expression of ATF4 protein]|glucose results in increased expression of ATF4 protein,,,PMID:34801538,https://www.ncbi.nlm.nih.gov/pubmed/34801538,34801538,,
186,1379270,126079,IUPHAR/BPS Guide to PHARMACOLOGY,"[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetic acid",451,XCC,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=451,20,A2B receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=20,P29275,Adenosine receptor A2b,136,ADORA2B,9606,Homo sapiens (human),Antagonist,pKi,7.3,PMID:11266650,https://www.ncbi.nlm.nih.gov/pubmed/11266650,11266650,,
187,1379271,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0000324,Thymidylate synthase,https://www.drugbank.ca/bio_entities/BE0000324,P04818,Thymidylate synthase,7298,TYMS,9606,Homo sapiens (human),Inhibitor,,,PMID:24284432,https://www.ncbi.nlm.nih.gov/pubmed/24284432,24284432,,
188,1379272,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0001240,Bifunctional purine biosynthesis protein PURH,https://www.drugbank.ca/bio_entities/BE0001240,P31939,Bifunctional purine biosynthesis protein ATIC,471,ATIC,9606,Homo sapiens (human),Inhibitor,,,PMID:24284432,https://www.ncbi.nlm.nih.gov/pubmed/24284432,24284432,,
189,1379273,126941,DrugBank,Methotrexate,DB00563,Methotrexate,https://www.drugbank.ca/drugs/DB00563,BE0000330,Dihydrofolate reductase,https://www.drugbank.ca/bio_entities/BE0000330,P00374,Dihydrofolate reductase,1719,DHFR,9606,Homo sapiens (human),Inhibitor,,,PMID:16971132|PMID:17333344|PMID:17130456|PMID:11752352|PMID:16647263|PMID:16936229|PMID:24284432,https://www.ncbi.nlm.nih.gov/pubmed/16971132|https://www.ncbi.nlm.nih.gov/pubmed/17333344|https://www.ncbi.nlm.nih.gov/pubmed/17130456|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/16647263|https://www.ncbi.nlm.nih.gov/pubmed/16936229|https://www.ncbi.nlm.nih.gov/pubmed/24284432,16971132|17333344|17130456|11752352|16647263|16936229|24284432,,
190,1953165,10313045,Comparative Toxicogenomics Database (CTD),"Iron, isotope of mass 56",D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622,SNCA,9606,Homo sapiens (human),Iron promotes the reaction [SNCA protein binds to SNCA protein],,,PMID:18823621,https://www.ncbi.nlm.nih.gov/pubmed/18823621,18823621,,
191,1953166,10313045,Comparative Toxicogenomics Database (CTD),"Iron, isotope of mass 56",D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,9606,Homo sapiens (human),"SOD1 protein inhibits the reaction [asbestos, crocidolite results in increased uptake of iron]",,,PMID:16272461,https://www.ncbi.nlm.nih.gov/pubmed/16272461,16272461,,
192,1953167,10313045,Comparative Toxicogenomics Database (CTD),"Iron, isotope of mass 56",D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,10090,Mus musculus (house mouse),Iron promotes the reaction [corn oil results in decreased activity of SOD1 protein]|[corn oil co-treated with iron] results in decreased activity of SOD1 protein,,,PMID:17194920,https://www.ncbi.nlm.nih.gov/pubmed/17194920,17194920,,
193,1987606,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966,REL,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of REL mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
194,1987607,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971,RELB,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RELB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
195,1987608,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,11079,RER1,https://ctdbase.org/detail.go?type=gene&acc=11079,,,11079,RER1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RER1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
196,1987609,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,6576,SLC25A1,https://ctdbase.org/detail.go?type=gene&acc=6576,,,6576,SLC25A1,10090,Mus musculus (house mouse),[sodium glutamate co-treated with trans fatty acids] results in increased expression of SLC25A1 mRNA,,,PMID:19001666,https://www.ncbi.nlm.nih.gov/pubmed/19001666,19001666,,
197,1987610,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,1468,SLC25A10,https://ctdbase.org/detail.go?type=gene&acc=1468,,,1468,SLC25A10,10090,Mus musculus (house mouse),[sodium glutamate co-treated with trans fatty acids] results in increased expression of SLC25A10 mRNA,,,PMID:19001666,https://www.ncbi.nlm.nih.gov/pubmed/19001666,19001666,,
198,1987611,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,8604,SLC25A12,https://ctdbase.org/detail.go?type=gene&acc=8604,,,8604,SLC25A12,10090,Mus musculus (house mouse),[sodium glutamate co-treated with high fructose corn syrup] results in decreased expression of SLC25A12 mRNA,,,PMID:20111022,https://www.ncbi.nlm.nih.gov/pubmed/20111022,20111022,,
199,1987612,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,114789,SLC25A25,https://ctdbase.org/detail.go?type=gene&acc=114789,,,114789,SLC25A25,10090,Mus musculus (house mouse),Sodium glutamate results in decreased expression of SLC25A25 mrna|[sodium glutamate co-treated with high fructose corn syrup] results in decreased expression of SLC25A25 mRNA,,,PMID:20111022,https://www.ncbi.nlm.nih.gov/pubmed/20111022,20111022,,
200,1987613,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,84275,SLC25A33,https://ctdbase.org/detail.go?type=gene&acc=84275,,,84275,SLC25A33,10090,Mus musculus (house mouse),[sodium glutamate co-treated with high fructose corn syrup] results in decreased expression of SLC25A33 mrna|sodium glutamate results in decreased expression of SLC25A33 mRNA,,,PMID:20111022,https://www.ncbi.nlm.nih.gov/pubmed/20111022,20111022,,
